Michelle Iris Jakobsen (M I Jakobsen, Michelle I Jakobsen)

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Replacement Therapy

Cross Sectional

Bipolar Disorder

Prognostic Factors

Top Venues

Nordic journal of psychiatry

Schizophrenia (Heidelberg, Germany)

Acta psychiatrica Scandinavica

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonsen
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Michelle Iris Jakobsen, Stephen Fitzgerald Austin, Ole Jakob Storebø, Jimmi Nielsen, Erik Simonsen
Non-prescribing of clozapine for outpatients with schizophrenia in real-world settings: The clinicians' perspectives. Schizophrenia (Heidelberg, Germany) 9 (1) (2023)
Michelle Iris Jakobsen, Julie P Schaug, Jimmi Nielsen, Erik Simonsen
Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit. Nordic journal of psychiatry (2023)
Michelle Iris Jakobsen, Julie P Schaug, Jimmi Nielsen, Erik Simonsen
Antipsychotic prescribing practices for outpatients with schizophrenia and reasons for non-clozapine treatment - Data from a Danish quality assessment audit. Nordic journal of psychiatry (2023)
Michelle Iris Jakobsen, H Grønborg, H V Hansen, A Fink-Jensen
Clozapine-associated neutropenia following augmentation with sodium valproate. SAGE open medical case reports 9 (2021)
Michelle Iris Jakobsen, Ole Jakob Storebø, Stephen Fitzgerald Austin, Jimmi Nielsen, Erik Simonsen
Patients' and psychiatrists' perspectives on clozapine treatment-a scoping review protocol. BMJ open 11 (10) (2021)
C K Svensson, J R Larsen, L Vedtofte, M S L Jakobsen, H R Jespersen, Michelle Iris Jakobsen, K Koyuncu, O Schjerning, J Nielsen, C T Ekstrøm, Christoph U Correll, T Vilsbøll, A Fink-Jensen
One-year follow-up on liraglutide treatment for prediabetes and overweight/obesity in clozapine- or olanzapine-treated patients. Acta psychiatrica Scandinavica 139 (1) (2018)